234 related articles for article (PubMed ID: 10855643)
61. Tumor uptake and metabolism of copper-67-labeled monoclonal antibody chCE7 in nude mice bearing neuroblastoma xenografts.
Novak-Hofer I; Zimmermann K; Maecke HR; Amstutz HP; Carrel F; Schubiger PA
J Nucl Med; 1997 Apr; 38(4):536-44. PubMed ID: 9098198
[TBL] [Abstract][Full Text] [Related]
62. Glomerular filtration rate after alpha-radioimmunotherapy with 211At-MX35-F(ab')2: a long-term study of renal function in nude mice.
Bäck T; Haraldsson B; Hultborn R; Jensen H; Johansson ME; Lindegren S; Jacobsson L
Cancer Biother Radiopharm; 2009 Dec; 24(6):649-58. PubMed ID: 20025544
[TBL] [Abstract][Full Text] [Related]
63. Intratumoral and whole-body distributions of C110 anti-carcinoembryonic antigen radioimmunotoxin after intraperitoneal and intravenous injection: a quantitative autoradiographic study.
Ito T; Griffin TW; Collins JA; Brill AB
Cancer Res; 1992 Apr; 52(7):1961-7. PubMed ID: 1551124
[TBL] [Abstract][Full Text] [Related]
64. Improved treatment of medullary thyroid cancer in a nude mouse model by combined radioimmunochemotherapy: doxorubicin potentiates the therapeutic efficacy of radiolabeled antibodies in a radioresistant tumor type.
Behr TM; Wulst E; Radetzky S; Blumenthal RD; Dunn RM; Gratz S; Rave-Fränk M; Schmidberger H; Raue F; Becker W
Cancer Res; 1997 Dec; 57(23):5309-19. PubMed ID: 9393755
[TBL] [Abstract][Full Text] [Related]
65. Biological properties of biotin-chelate conjugates for pretargeted diagnosis and therapy with the avidin/biotin system.
Goodwin DA; Meares CF; Osen M
J Nucl Med; 1998 Oct; 39(10):1813-8. PubMed ID: 9776294
[TBL] [Abstract][Full Text] [Related]
66. Pretargeted radioimmunoscintigraphy in patients with primary colorectal cancer using a bispecific anticarcinoembryonic antigen CEA X anti-di-diethylenetriaminepentaacetic acid F(ab')2 antibody.
Aarts F; Boerman OC; Sharkey RM; Hendriks T; Chang CH; McBride WJ; Bleichrodt RP; Oyen WJ; Goldenberg DM
Cancer; 2010 Feb; 116(4 Suppl):1111-7. PubMed ID: 20127959
[TBL] [Abstract][Full Text] [Related]
67. Pre-clinical and clinical studies of two new bifunctional chelating agents for immunoscintigraphy with 111In-anti-CEA monoclonal antibody.
Faivre-Chauvet A; Mease RC; Chetanneau A; Bardiès M; Sai-Maurel C; Meinken GE; Srivastava SC; Chatal JF; Gestin JF
Nucl Med Commun; 1996 Sep; 17(9):781-9. PubMed ID: 8895905
[TBL] [Abstract][Full Text] [Related]
68. Differences in biodistribution of the anti-(carcinoembryonic antigen) murine monoclonal antibody CE-25, its F(ab')2 fragment and its intact mainly human chimeric form CE 4-8-13. Dependence on tumour size and amount of antibody injected.
Westera G; Rülicke T; Smith A; Duewell S
Cancer Immunol Immunother; 1994 Dec; 39(6):375-82. PubMed ID: 8001025
[TBL] [Abstract][Full Text] [Related]
69. 211At radioimmunotherapy of subcutaneous human ovarian cancer xenografts: evaluation of relative biologic effectiveness of an alpha-emitter in vivo.
Bäck T; Andersson H; Divgi CR; Hultborn R; Jensen H; Lindegren S; Palm S; Jacobsson L
J Nucl Med; 2005 Dec; 46(12):2061-7. PubMed ID: 16330571
[TBL] [Abstract][Full Text] [Related]
70. Applicability of carcinoembryonic antigen-specific monoclonal antibodies to radioimmunoguided surgery for human colorectal carcinoma.
Kim JC; Kim WS; Ryu JS; Oh SJ; Lee DH; Koo KH; Roh SA; Kim HC; Yu CS; Kang GH; Bodmer WF
Cancer Res; 2000 Sep; 60(17):4825-9. PubMed ID: 10987293
[TBL] [Abstract][Full Text] [Related]
71. Preclinical characterization and in vivo imaging studies of an engineered recombinant technetium-99m-labeled metallothionein-containing anti-carcinoembryonic antigen single-chain antibody.
Pietersz GA; Patrick MR; Chester KA
J Nucl Med; 1998 Jan; 39(1):47-56. PubMed ID: 9443738
[TBL] [Abstract][Full Text] [Related]
72. Cytokine targeting in tumors using a bispecific antibody directed against carcinoembryonic antigen and tumor necrosis factor alpha.
Robert B; Mach JP; Mani JC; Ychou M; Folli S; Artus JC; Pèlegrin A
Cancer Res; 1996 Oct; 56(20):4758-65. PubMed ID: 8840995
[TBL] [Abstract][Full Text] [Related]
73. Regional and systemic distribution of anti-tumor x anti-CD3 heteroaggregate antibodies and cultured human peripheral blood lymphocytes in a human colon cancer xenograft.
Nelson H; Ramsey PS; Kerr LA; McKean DJ; Donohue JH
J Immunol; 1990 Nov; 145(10):3507-15. PubMed ID: 1700013
[TBL] [Abstract][Full Text] [Related]
74. Biodistribution and tumor imaging of an anti-CEA single-chain antibody-albumin fusion protein.
Yazaki PJ; Kassa T; Cheung CW; Crow DM; Sherman MA; Bading JR; Anderson AL; Colcher D; Raubitschek A
Nucl Med Biol; 2008 Feb; 35(2):151-8. PubMed ID: 18312824
[TBL] [Abstract][Full Text] [Related]
75. Preclinical radioimmunotargeting of folate receptor alpha using the monoclonal antibody conjugate DOTA-MORAb-003.
Smith-Jones PM; Pandit-Taskar N; Cao W; O'Donoghue J; Philips MD; Carrasquillo J; Konner JA; Old LJ; Larson SM
Nucl Med Biol; 2008 Apr; 35(3):343-51. PubMed ID: 18355690
[TBL] [Abstract][Full Text] [Related]
76. Avidin chase can reduce myelotoxicity associated with radioimmunotherapy of experimental liver micrometastases in mice.
Sato N; Saga T; Sakahara H; Nakamoto Y; Zhao S; Kuroki M; Iida Y; Endo K; Konishi J
Jpn J Cancer Res; 2000 Jun; 91(6):622-8. PubMed ID: 10874215
[TBL] [Abstract][Full Text] [Related]
77. Biodistribution of 99mTc-labeled anti-human epidermal growth factor receptor (EGF-R) humanized monoclonal antibody h-R3 in a xenograft model of human lung adenocarcinoma.
Morales-Morales A; Ducongé J; Caballero-Torres I; Núñez-Gandolff G; Fernández E; Iznaga-Escobar N
Nucl Med Biol; 1999 Apr; 26(3):275-9. PubMed ID: 10363798
[TBL] [Abstract][Full Text] [Related]
78. Pharmacokinetics of 111In-labelled monoclonal antibody ZCE-025 and fragments in tumour-bearing mice.
Koziol JA; Lee PP; Dillman RO; Fagnani R; Halpern SE
Nucl Med Commun; 1995 Apr; 16(4):299-305. PubMed ID: 7624111
[TBL] [Abstract][Full Text] [Related]
79. Radioimmunoimaging with mixed monoclonal antibodies of nude mice bearing human lung adenocarcinoma xenografts.
Duan D; Li SL; Zhu YQ; Zhang T; Lei CM; Cheng XH
Asian Pac J Cancer Prev; 2012; 13(9):4255-61. PubMed ID: 23167324
[TBL] [Abstract][Full Text] [Related]
80. Radiolabeling and biological evaluation of DOTA-Ph-Al derivative conjugated to anti-EGFR antibody ior egf/r3 for targeted tumor imaging and therapy.
Pnwar P; Iznaga-Escobar N; Mishra P; Srivastava V; Sharma RK; Chandra R; Mishra AK
Cancer Biol Ther; 2005 Aug; 4(8):854-60. PubMed ID: 16082184
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
